Samsung Invests in U.S. Cartography Biosciences, Focusing on Next-Generation Anticancer Technology; Expanding Global Cooperation on Antigen Discovery Based on Single-Cell Gene Data. The Samsung Life Science Fund [invests] in Cartography Biosciences, a U.S. bio-venture company